GlassScriptPhysician profile
Steven P Eyre
NPI 1174520597
$1,389.99
in general payments reported to CMS, 2019-2025
16 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Procedural Dermatology provider received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $50.95 · 2021: $204 · 2022: $291 · 2023: $436 · 2024: $83.53 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $659.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $274.31 | 2019-2025 | Bimzelx, Cimzia |
| Amgen INC. | $190.62 | 2022-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $157.73 | 2019-2024 | |
| Dermavant Sciences, INC. | $126.17 | 2023 | Vtama |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.34 | 2025 | Spevigo |
| Pfizer INC. | $62.02 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $59.96 | 2022-2023 | Sotyktu |
| Paratek Pharmaceuticals, INC. | $59.08 | 2022-2023 | Nuzyra |
| Janssen Biotech, INC. | $58.81 | 2019-2022 | |
| Stemline Therapeutics INC. | $57.11 | 2021 | |
| Abbvie INC. | $49.35 | 2019-2023 | |
| Incyte Corporation | $49.22 | 2021 | |
| Sun Pharmaceutical Industries INC. | $39.15 | 2022-2023 | Absorica Ld, Winlevi |
| Novartis Pharmaceuticals Corporation | $37.55 | 2019-2023 | |
| Arcutis Biotherapeutics, INC. | $34.01 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epi Health, LLC | $24.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Eyre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.